First BanCorp Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
First BanCorp Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2019-03-31 | 2018-03-31 | 2017-03-31 | 2016-03-31 | 2015-03-31 | 2014-03-31 |
---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||
net income | 43,314,000 | 33,148,000 | 25,541,000 | 23,344,000 | 25,646,000 | 17,083,000 |
adjustments to reconcile net income to net cash from operating activities: | ||||||
depreciation and amortization | 4,449,000 | 3,922,000 | 4,141,000 | 4,588,000 | ||
amortization of intangible assets | 799,000 | 1,006,000 | 1,121,000 | 1,214,000 | 1,093,000 | 1,235,000 |
benefit from credit losses - | ||||||
deferred income tax expense | 13,900,000 | 5,472,000 | 3,635,000 | 2,060,000 | ||
stock-based compensation | 1,018,000 | 2,205,000 | 1,734,000 | 1,557,000 | 1,457,000 | 717,000 |
unrealized gain on derivative instruments | ||||||
net (gain) loss on disposals or sales of premises and equipment and other assets | ||||||
net gain on sales of loans | -1,536,000 | -1,096,000 | -1,472,000 | -2,488,000 | -1,689,000 | -2,017,000 |
net amortization/accretion of premiums, discounts, and deferred loan fees and costs | -2,023,000 | -2,095,000 | -2,031,000 | |||
originations and purchases of loans held for sale | -74,225,000 | -65,984,000 | -81,389,000 | -107,034,000 | -89,425,000 | -72,748,000 |
sales and repayments of loans held for sale | 78,654,000 | 76,163,000 | 86,924,000 | 108,615,000 | 87,051,000 | 72,865,000 |
amortization of broker placement fees | 189,000 | 367,000 | 527,000 | 858,000 | 1,335,000 | 1,785,000 |
net amortization of premiums and discounts on investment securities | ||||||
increase in accrued interest receivable | -669,000 | |||||
increase in other assets | 3,081,000 | |||||
increase in other liabilities | -7,053,000 | 166,000 | 8,517,000 | -11,167,000 | 11,007,000 | -4,987,000 |
cash flows from investing activities: | ||||||
net (disbursements) repayments on loans held for investment | ||||||
proceeds from sales of loans held for investment | 4,998,000 | 13,274,000 | 53,245,000 | 2,230,000 | 16,558,000 | |
proceeds from sales of repossessed assets | 11,250,000 | 10,559,000 | 12,159,000 | 12,375,000 | 18,446,000 | 12,262,000 |
purchases of available-for-sale debt securities | ||||||
proceeds from principal repayments and maturities of available-for-sale debt securities | ||||||
purchases of held-to-maturity debt securities | ||||||
proceeds from principal repayments and maturities of held-to-maturity debt securities | ||||||
additions to premises and equipment | -4,046,000 | -5,142,000 | -2,840,000 | -3,006,000 | -3,027,000 | -7,696,000 |
proceeds from sales of premises and equipment and other assets | ||||||
net purchases of other investment securities | ||||||
payment related to previous acquisition | ||||||
cash flows from financing activities: | ||||||
net increase in deposits | 84,436,000 | 45,026,000 | 58,722,000 | 95,879,000 | -166,924,000 | 120,977,000 |
repayments of long-term borrowings | ||||||
repurchase of outstanding common stock | -1,882,000 | -2,624,000 | -528,000 | -259,000 | -236,000 | -246,000 |
dividends paid on common stock | -6,538,000 | |||||
dividends paid on preferred stock | -669,000 | -669,000 | -669,000 | |||
net increase in cash and cash equivalents | 3,372,000 | 127,429,000 | 124,437,000 | 274,367,000 | 188,328,000 | 185,826,000 |
cash and cash equivalents at beginning of period | 586,203,000 | 716,395,000 | 299,685,000 | 752,458,000 | 796,108,000 | 655,671,000 |
cash and cash equivalents at end of period | 589,575,000 | 843,824,000 | 424,122,000 | 1,026,825,000 | 984,436,000 | 841,497,000 |
cash and cash equivalents include: | ||||||
cash and due from banks | 581,838,000 | 743,409,000 | 414,034,000 | 813,732,000 | 767,471,000 | 824,547,000 |
the accompanying notes are an integral part of these financial statements. | ||||||
benefit from loan and lease losses | 11,820,000 | 20,544,000 | 25,442,000 | 21,053,000 | 32,970,000 | 31,915,000 |
gain on early extinguishment of debt | -2,316,000 | -4,217,000 | ||||
otti on debt securities | ||||||
net gain on sales of premises and equipment and other assets | -17,000 | |||||
net amortization/accretion of premiums, discounts and deferred loan fees and costs | -2,343,000 | -673,000 | ||||
net amortization/accretion of premium and discounts on investment securities | 476,000 | 461,000 | 447,000 | 1,269,000 | ||
decrease in accrued interest receivable | 13,061,000 | 3,413,000 | 3,806,000 | 1,953,000 | ||
increase in accrued interest payable | 736,000 | 8,000 | 174,000 | 2,257,000 | 1,000,000 | 2,106,000 |
decrease (increase) in other assets | ||||||
net cash from operating activities | 82,982,000 | 95,376,000 | 84,803,000 | 54,277,000 | 75,513,000 | 73,508,000 |
principal collected on loans | 642,758,000 | 590,753,000 | 669,615,000 | 735,801,000 | 751,062,000 | 776,086,000 |
loans originated and purchased | -817,900,000 | -550,257,000 | -704,175,000 | -627,105,000 | -705,621,000 | -774,764,000 |
purchases of available-for-sale securities | -49,626,000 | -5,003,000 | ||||
proceeds from principal repayments and maturities of available-for-sale securities | 57,809,000 | 100,195,000 | 53,830,000 | |||
proceeds from principal repayments of held-to-maturity securities | 142,000 | 141,000 | ||||
proceeds from sale of premises and equipment and other assets | 18,000 | 1,857,000 | 637,000 | 2,492,000 | 25,000 | |
net redemptions/purchase of other investment securities | ||||||
proceeds from the settlement of insurance claims | ||||||
net cash from investing activities | -104,871,000 | 111,754,000 | 82,109,000 | 131,495,000 | 279,975,000 | -8,360,000 |
repayment of securities sold under agreements to repurchase | ||||||
net fhlb advances repayments | ||||||
repayment of junior subordinated debentures | -21,434,000 | -7,025,000 | ||||
net cash from financing activities | 25,261,000 | -79,701,000 | -42,475,000 | 88,595,000 | -167,160,000 | 120,678,000 |
money market instruments | 7,737,000 | 100,415,000 | 10,088,000 | 213,093,000 | 216,965,000 | 16,950,000 |
the accompanying notes are an integral part of these statements. | ||||||
unrealized (gain) loss on derivative instruments | ||||||
loans held for sale valuation adjustments | ||||||
decrease in other assets | 14,176,000 | 10,566,000 | 5,419,000 | 3,320,000 | 8,657,000 | |
change in securities sold under agreements to repurchase | -50,086,000 | -100,000,000 | ||||
unrealized loss on derivative instruments | -589,000 | 52,000 | 57,000 | 153,000 | ||
loans held for sale valuation adjustment | 558,000 | |||||
net amortization/accretion of premiums and discounts on investment securities | 39,000 | |||||
net redemptions/purchases of other investment securities | 100,000 | |||||
deferred income tax (benefit) expense | -6,016,000 | -700,000 | ||||
gain on sale of investments | ||||||
gain from recovery of investments previously written off | ||||||
gain from insurance proceeds | ||||||
decrease (increase) in accrued interest receivable | 4,992,000 | |||||
proceeds from sales of available-for-sale securities | 14,990,000 | |||||
proceeds from recovery of investments previously written off | ||||||
net redemptions/purchases of other investments securities | ||||||
proceeds from settlement of insurance claims | ||||||
net cash outflows from purchase/sale of insurance contracts | ||||||
net fhlb advances proceeds | ||||||
cash and cash equivalents at beginning of year | ||||||
cash and cash equivalents at end of year | ||||||
net fhlb advances (repayments) proceeds | ||||||
other-than-temporary impairments on debt securities | 12,231,000 | 6,687,000 | 156,000 | |||
net (gain) loss on sales of premises and equipment and other assets | -847,000 | |||||
net redemptions of other equity securities | ||||||
net fhlb advances paid | -100,000,000 | |||||
gain on sales of investments | ||||||
bargain purchase gain | -13,443,000 | |||||
gain on sale of merchant contracts | ||||||
impairment of fixed assets | ||||||
increase increase in accrued interest payable | ||||||
purchases of held-to-maturity investment securities | ||||||
proceeds from principal repayments and maturities of held-to-maturity securities | 141,000 | |||||
proceeds from sale of merchant contracts | ||||||
net purchases/sales of other equity securities | ||||||
net cash received from acquisition | 217,659,000 | |||||
net purchase/sales of other equity securities | ||||||
net decrease in deposits | ||||||
loss on sales of premises and equipment and other assets | 9,000 | |||||
net redemptions (purchases) of other equity securities | 4,500,000 | |||||
purchase of insurance contracts | -1,067,000 | |||||
equity in loss of unconsolidated entity | 6,610,000 | |||||
gain on sales of premises and equipment and other assets | ||||||
gain on extinguishment of debt | ||||||
proceeds from principal repayments and maturities of securities held to maturity | ||||||
net (purchases) redemptions/sales of other equity securities | ||||||
repayments of junior subordinated debentures | ||||||
issuance costs of common stock issued in exchange for preferred stock | ||||||
series a through e | ||||||
net decrease in cash and cash equivalents | ||||||
net gain on disposition of premises and equipment and other assets | ||||||
purchases of securities held to maturity | ||||||
repayment of fhlb advances | ||||||
purchase of securities held to maturity | ||||||
purchases of other equity securities | -141,000 | -433,000 | ||||
purchases of securities available for sale | -62,770,000 | -56,429,000 | -76,253,000 | |||
proceeds from principal repayments and maturities of securities available for sale | 62,418,000 | 53,596,000 | 45,422,000 | |||
other-than-temporary impairments on equity securities | ||||||
impairment of collateral pledged to lehman | ||||||
depreciation | 5,306,000 | 5,453,000 | ||||
deferred income tax benefit | ||||||
(gain) loss on sales of premises and equipment and other assets | ||||||
repurchases of outstanding common stock | ||||||
issuance costs of common stock issued in exchange for preferred stock series a through e | -53,000 | |||||
increase in accrued income tax payable | 5,481,000 | 1,476,000 | ||||
net purchases of other equity securities | ||||||
derivative instruments and financial liabilities measured at fair value, unrealized loss | 72,000 | |||||
gain on sale of premises and equipment and other assets | -194,000 | -25,000 | ||||
derivative instruments and financial liabilities measured at fair value, | ||||||
unrealized gain | ||||||
net redemptions/sales (purchases) of other equity securities | ||||||
net repayments of securities sold under agreements to repurchase | ||||||
repayments of medium-term notes | ||||||
proceeds from common stock sold, net of costs | ||||||
derivative instruments and financial liabilities measured at fair value, gain | -148,000 | |||||
net amortization of premiums, discounts and deferred loan fees and costs | -477,000 | |||||
net amortization of premium and discounts on investment securities | -284,000 | |||||
net redemptions/sales of other equity securities | ||||||
proceeds from sale of premises and equipments and other assets | ||||||
loss on early extinguishment of borrowings | ||||||
derivative instruments and financial liabilities measured at fair value, (gain) loss | ||||||
(gain) loss on sale of premises and equipment and other assets | ||||||
net amortization of premiums, discounts, and deferred loan fees and costs | ||||||
proceeds from sales of held-to-maturity securities | ||||||
proceeds from sales of premises and equipments and other assets | ||||||
proceeds from securities litigation settlement and other proceeds | ||||||
net repayments and cancellation costs of securities sold under agreements to repurchase | ||||||
net fhlb advances (paid) proceeds and cancellation costs | ||||||
dividends paid | ||||||
amortization and impairment of intangible assets | ||||||
proceeds from sale of loans held for investment | ||||||
proceeds from sale of repossessed assets | ||||||
net fhlb advances (paid) proceeds | ||||||
proceeds from common stock sold |
We provide you with 20 years of cash flow statements for First BanCorp stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of First BanCorp stock. Explore the full financial landscape of First BanCorp stock with our expertly curated income statements.
The information provided in this report about First BanCorp stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.